News | Magnetic Resonance Imaging (MRI) | February 01, 2016

MRI Found Safe, Effective for Patients with Implantable Cardiac Devices

Researchers at Allegheny General Hospital found MRI scan led to change in diagnosis for large number of patient cases

Allegheny General Hospital, MRI, patients with implantable cardiac devices, safety and effectiveness

February 1, 2016 — The findings of a major study led by cardiovascular imaging specialists at Allegheny General Hospital (AGH) suggest magnetic resonance imaging (MRI) is a safe and effective diagnostic procedure for patients with implantable cardiac devices. The research, believed to be the first ever focused solely on the value of MRI in this patient population, is being presented at the annual Society of Cardiovascular MRI (SCMR) Scientific Sessions meeting in Los Angeles.

“Having already established the safety of MRI for patients with these devices when performed at cardiac MRI centers with advanced capabilities, it was important to determine if significant life-saving or life-changing diagnoses could also be made based on the results of the MRI,” said Robert Biederman, M.D., medical director of the Cardiovascular MRI Center at AGH’s Cardiovascular Institute and one of the lead researchers on the study. “This ongoing study has shown that using MRI on patients with implanted pacemakers and defibrillators has added substantial clinical value to patient diagnosis and subsequent patient management, justifying the risk of the procedure.

“Now that we have been able to minimize the risks of MRI to patients with these implanted devices, it was crucial to prove the value of using what has really become the imaging tool of choice for countless clinical diagnoses,” added Biederman, who served as moderator for the SCMR’s opening session.

Over the last several years, AGH specialists evaluated 157 patients. That included 114 neurology/neurosurgery cases, 36 cardiovascular cases and seven musculoskeletal cases. For 88 percent of the neurology/neurosurgery cases, the MRI scan added value to the final diagnoses – with 18 percent of those cases seeing a change to the original diagnoses thanks to the use of MRI. And 92 percent of the cardiac cases saw a benefit from the use of MRI, while 100 percent of the musculoskeletal cases realized a benefit from using MRI. Additionally, Biederman reported, there were no adverse clinical events associated with it for any of the patients studied.

Approximately 3 million Americans currently have an implanted cardiac device and hundreds of thousands more receive them each year. It is estimated that as many as three-quarters of those who have a pacemaker or implantable cardioverter defibrillator (ICD) will require an MRI at some point in their lifetimes.

“MRI is simply too important a diagnostic tool not to be able to have it in our arsenal to evaluate and help determine the best treatment for patients who have an implanted device,” said Biederman. “Once the safety of using it had been established, there was still some question about its ultimate value. We believe the results of this study provide a clear and resounding answer to that question.”

Under Biederman’s direction, patients with implanted cardiac devices who are referred for MRI at the hospital undergo an extensive evaluation of their cardiovascular health and level of device dependence.

Once a patient is cleared to undergo MRI, Biederman and his team perform a baseline device interrogation and then convert the pacemaker and/or defibrillator to a safer mode of operation for the length of the test. If patients are determined to be non-pacemaker dependent under baseline conditions, the device may be turned off completely while the imaging takes place, further reducing but not eliminating risk. Additionally, manipulations of the MRI environment to minimize likelihood of heating, induction of radio-frequency energy and triggering of certain potentially lethal rhythms are performed.

During the procedure, a patient’s heart rhythm is monitored in real-time in the MRI suite and the entire process is closely supervised by Biederman, cardiovascular physicist Moneal Shah, M.D., and the Cardiovascular MRI Center’s team of nurses and technologists. Once the MRI is completed, the implanted device is reprogrammed to its original settings.

For more information: www.ahn.org

Related Content

This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
SBRT Considered Safe Treatment Option for Patients With Multiple Metastases
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (SBRT) could be used...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...
Cardiac Ultrasound Software Streamlines Fetal Heart Exams
Feature | Cardiovascular Ultrasound | October 30, 2018
A new tool called fetalHQ on GE Healthcare’s Voluson ultrasound systems is the first tool to simultaneously examine the...
Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer. ASTRO 2018 #ASTRO2018 #ASTRO #ASTRO18

Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer.

News | Radiation Oncology | October 30, 2018
October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to